Paradoxically, some clinical trials report decreased circulating copper levels in PD patients compared to healthy controls [136], which may occur, because by binding to ceruloplasmin, copper stimulates ferroxidase activity and participates in iron homeostasis. Here, CP is linked to Parkinson disease.